Good M F, Branigan J, Smith G, Houghten R A
Queensland Institute of Medical Research, Herston, Brisbane, Australia.
Pept Res. 1990 May-Jun;3(3):110-5.
We have studied the proliferative and helper T cell responses in mice to a malaria sporozoite vaccine candidate currently undergoing human trials. Following immunization of B10 (I-Ab) mice with the purified recombinant baculovirus-expressed Plasmodium falciparum circumsporozoite protein, draining lymph node cells were challenged in vitro with a series of overlapping synthetic peptides which span the construct. Surprisingly, only a single peptide from the protein was immunodominant in that it could reproducibly elicit a significant proliferative response from the immunized lymph node cells. This epitope, (NANP)n, is also the repetitive immunodominant B cell epitope of the protein. However, immunization of mice with synthetic peptides revealed at least 3 cryptic proliferative epitopes--epitopes not revealed by protein immunization--two of which represent conserved regions of the protein. While cryptic peptide-immunization did not elicit protein-specific proliferative T cells, it did reveal protein-specific helper T cells, as shown by an in vivo assay. Identification of "cryptic" epitopes not only for malaria but for other infectious diseases may aid vaccine design, especially in situations where subunit vaccines are sought.
我们研究了小鼠对一种目前正在进行人体试验的疟疾子孢子疫苗候选物的增殖性T细胞反应和辅助性T细胞反应。用纯化的重组杆状病毒表达的恶性疟原虫环子孢子蛋白免疫B10(I-Ab)小鼠后,引流淋巴结细胞在体外受到一系列跨越该构建体的重叠合成肽的刺激。令人惊讶的是,该蛋白中只有一个肽具有免疫显性,因为它能反复引发免疫的淋巴结细胞产生显著的增殖反应。这个表位(NANP)n也是该蛋白重复的免疫显性B细胞表位。然而,用合成肽免疫小鼠发现了至少3个隐蔽的增殖性表位——蛋白免疫未揭示的表位——其中两个代表该蛋白的保守区域。虽然隐蔽肽免疫没有引发蛋白特异性增殖性T细胞,但如体内试验所示,它确实揭示了蛋白特异性辅助性T细胞。识别不仅针对疟疾而且针对其他传染病的“隐蔽”表位可能有助于疫苗设计,特别是在寻求亚单位疫苗的情况下。